In 2011, Biofarm reported net profit of RON14.2 million.
According to its revenue and expenditure budget for 2012, the pharmaceuticals company forecasts total sales of RON100.6 million, up 7.7% on the year.
The company has scheduled investments worth around RON30 million in 2012.
Biofarm’s shareholders approved paying out a gross dividend of RON0.01 a share from the 2011 profit, nearly double of the year. Total dividends will reach RON11 million.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 54% of Biofarm’s shares.
On the Bucharest bourse April 20, Biofarm closed up 0.16% to RON0.1905 a share. (EUR1=RON4.3791)